Novavax vaccine 90 per cent effective

By Carl O'Donnell
Updated June 14 2021 - 8:26pm, first published 8:19pm
Novavax says data from trials shows its vaccine is more than 90 per cent effective against COVID.
Novavax says data from trials shows its vaccine is more than 90 per cent effective against COVID.

Novavax Inc has reported late-stage data from its US-based clinical trial showing its vaccine is more than 90 per cent effective against COVID-19 across a variety of variants of the virus.

Subscribe now for unlimited access.

$0/

(min cost $0)

or signup to continue reading

See subscription options